Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Canadian Junior Resource Roundup -- Ignore unavailable to you. Want to Upgrade?

To: ogi who wrote (4402)	11/24/2017 10:03:36 AM
From: ayeyou	Read Replies (1) \| Respond to of 4478

Exactly why I try and steer clear of highly overvalued spec plays. Edgy shareholders with quick fingers on the sell button. I never did see NVO worth anything like the valuation given it. I see fair value for NVO at about double what ARV's MC is. That would put it about $2.00 a share . It sure did fill that gap though ,hit low of $5.04 , recovering now but for how long?

To: ogi who wrote (4402)	11/24/2017 10:13:49 AM
From: WalterWhite	1 Recommendation Recommended By downandout Read Replies (1) \| Respond to of 4478

*Wow, that happened in a FLASH!!* The force is strong with you Ogi :) Comments made by RR and others convinced me to exit at 7.38. I am not a chartist, but comments about that gap were well founded. Sometimes it is wise to listen to others. NVO was a huge gainer for me, and maybe will be once again in 2018. We'll see if this story is kick started in January with drill and trenching assays.